Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX6F5S
|
||||
| Drug Name |
N-(3-methyl-1-(4-(trifluoromethoxy)phenylamino)butan-2-yl)-4-morpholino-4-oxo-2-phenethylbutanamide
|
||||
| Synonyms |
CHEMBL489942
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C28H36F3N3O4
|
||||
| Canonical SMILES |
CC(C)C(CNc1ccc(OC(F)(F)F)cc1)NC(=O)C(CCc2ccccc2)CC(=O)N3CCOCC3
|
||||
| InChI |
InChI=1S/C28H36F3N3O4/c1-20(2)25(19-32-23-10-12-24(13-11-23)38-28(29,30)31)33-27(36)22(9-8-21-6-4-3-5-7-21)18-26(35)34-14-16-37-17-15-34/h3-7,10-13,20,22,25,32H,8-9,14-19H2,1-2H3,(H,33,36)
|
||||
| InChIKey |
JPFKZQDIUQZZNY-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.